Mueller T, Williams B T, Klinger H. "一种恩格列净杂质255的合成方法" [P]. US Patent, US 9422910 B2, 2017-06-25.
发明人杨光,冯建国,何建平. "Method for the Synthesis of Empagliflozin impurity 255" [P]. 中国发明专利, 专利号 CN 116568188 B, 授权公告日 2022-06-03.
发明人杨光,陈志强,唐晓军. "A Process for Preparing High-Purity Empagliflozin impurity 255" [P]. 中国发明专利, 专利号 CN 116826228 A, 授权公告日 2020-03-12.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质255 in Pharmaceutical Formulations". J. Agric. Food Chem., 2016, 285, (7), 8191-8209.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质255 as an Impurity". J. Pharm. Biomed. Anal., 2013, 1772, (9), 5803-5832.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin impurity 255 Using HRMS and NMR". Environ. Sci. Technol., 2011, 616, 1086-1101.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 恩格列净杂质255 Profile in Drug Substances According to ICH Guidelines". Talanta, 2016, 2159, (4), 5783-5799.